Acute kidney injury in patients with cirrhosis: Prospective longitudinal study in 405 patients.

Background: Acute kidney injury (AKI) is common in patients with cirrhosis. In 2015, the International Club of Ascites (ICA) proposed new definitions of AKI in order to improve the prediction of outcomes. Our aim was to assess the prevalence and prognostic value of ICA 2015 - AKI criteria in hospitalised patients with cirrhosis.

[Hepatic and extra-hepatic manifestations of hepatitis E virus infection].

All patients with elevated transaminases in France should be tested for HEV infection. HEV can cause severe hepatitis, in particular in patients with chronic liver disease, pregnant women and the elderly. Extra-hepatic manifestations including a number of neurologic syndromes, thrombopenia and renal injury have been described.

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study.

Background: Data on infectious endocarditis (IE) in patients with liver cirrhosis (LC) are sparse. We aimed to describe the characteristics and predictors of mortality from IE in patients with LC.

Patients And Methods: Overall, 101 patients with LC and 101 controls with IE matched for sex, age, date of IE, and diabetes were retrospectively selected in 23 liver units between 2000 and 2013.

[Management of patients with decompensated liver cirrhosis].

Management of patients with decompensated liver Cirrhosis. The main objectives in the management of decompensated cirrhosis are to go back to a compensated phase and prevent the occurrence of complications such as ascites, encephalopathy, variceal bleeding, infection or liver failure. The treatment of the cause of the disease is crucial and liver transplantation should be discussed in every patient after a first decompensation of cirrhosis.

Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy.

Objective: To determine the clinical phenotype and outcome in hepatitis E virus-associated neuralgic amyotrophy (HEV-NA).

Methods: Cases of NA were identified in 11 centers from 7 European countries, with retrospective analysis of demographics, clinical/laboratory findings, and treatment and outcome. Cases of HEV-NA were compared with NA cases without evidence of HEV infection.